DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Slamon DJ, Neven P, Chia S. et al.
Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone
Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced
Breast Cancer: MONALEESA-3.
J Clin Oncol 2018;
36: 2465-2472
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.